Abstract: The disclosure provides a method of active immunotherapy for a cancer patient, comprising administering vaccines against Globo series antigens (i.e., Globo H, SSEA-3 and SSEA-4). Specifically, the method comprises administering Globo H-CRM197 (OBI-833/821) in patients with cancer. The disclosure also provides a method of selecting a cancer patient who is suitable as treatment candidate for immunotherapy. Exemplary immune response can be characterized by reduction of the severity of disease, including but not limited to, prevention of disease, delay in onset of disease, decreased severity of symptoms, decreased morbidity and delayed mortality.

Abstract: A heat dissipation device includes an air current producing unit and an electromagnet unit separately disposed on a substrate. The air current producing unit includes a resilient fan body mounted to the substrate and having an unrestrained end, and a magnetic component disposed on the fan body. The electromagnet unit is configured to generate a varying magnetic field that acts on the magnetic component so as to cause the fan body to sway, thereby producing air current.